XML 29 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 1,144.0 $ 769.0
Short-term investments (Note 7) 500.5 446.3
Accounts receivable, net of allowances of $8.3 and $7.9, respectively 775.1 643.0
Other receivables 61.8 56.1
Inventories (Note 5) 1,168.2 875.5
Prepaid expenses 146.8 110.0
Other current assets 239.3 195.9
Total current assets 4,035.7 3,095.8
Long-term investments (Note 7) 583.9 1,239.0
Property, plant, and equipment, net (Note 5) 1,749.4 1,632.8
Operating lease right-of-use assets (Note 6) 94.0 92.3
Goodwill (Note 10) 1,253.5 1,164.3
Other intangible assets, net (Note 10) 428.4 285.2
Deferred income taxes 754.6 484.0
Other assets 463.7 299.1
Total assets 9,363.2 8,292.5
Current liabilities    
Accounts payable 201.4 201.9
Accrued and other liabilities (Note 5) 969.1 795.0
Operating lease liabilities (Note 6) 24.9 25.5
Total current liabilities 1,195.4 1,022.4
Long-term debt (Note 11) 597.0 596.3
Contingent consideration liabilities (Note 12) 0.0 26.2
Taxes payable (Note 18) 80.6 143.4
Operating lease liabilities (Note 6) 73.0 69.5
Uncertain tax positions (Note 18) 339.3 267.5
Litigation settlement accrual (Note 3) 94.2 143.0
Other liabilities 264.3 217.5
Total liabilities 2,643.8 2,485.8
Commitments and contingencies (Notes 6, 11, and 19)
Stockholders' equity (Note 15)    
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding 0.0 0.0
Common stock, $1.00 par value, 1,050.0 shares authorized, 650.5 and 646.3 shares issued, and 601.1 and 608.3 shares outstanding, respectively 650.5 646.3
Additional paid-in capital 2,274.4 1,969.3
Retained earnings 8,992.4 7,590.0
Accumulated other comprehensive loss (Note 16) (242.8) (254.9)
Treasury stock, at cost, 49.4 and 38.0 shares, respectively (5,024.5) (4,144.0)
Total Edwards Lifesciences Corporation stockholders' equity 6,650.0 5,806.7
Noncontrolling interest (Note 9) 69.4 0.0
Total stockholders' equity 6,719.4 5,806.7
Total liabilities and stockholders' equity $ 9,363.2 $ 8,292.5